Latest News

09

September 2020

iX Biopharma has announced the allotment and issue of 44,491,299 Subscription Shares on 8 September 2020...

Read On

07

September 2020

Minutes for iX Biopharma’s Extraordinary General Meeting held on Friday, 4th September...

Read On

Our Sublingual Technology

Sublingual wafer administration offers the convenience of use over oral delivery, circumventing the drug breakdown in liver or gastrointestinal tract. The technology also provides rapid absorption, achieving maximum desirable therapeutic effect in a non-invasive manner.

Read On

Contact us

iX Biopharma Ltd

1 Kim Seng Promenade
#14-01 Great World City East Tower
Singapore 237994
T: +65 6235 2270
F: +65 6235 2170
E: info@ixbiopharma.com